CD19 and acute lymphoblastic leukemia: We recently reported that these cells are characterized co-expression of multiple ALL-associated human lymphoid differentiation antigens, including high levels of CD10, CD19, and CD34 that have been reported as markers of putative leukemic stem cells in B-precursor ALL [11].